Medroxyprogesterone acetate (depo-provera) vs. hydroxyprogesterone caproate (delalutin) in women with metastatic endometrial adenocarcinoma

M. Steven Piver, Joseph J. Barlow, John R. Lurain, Leslie E. Blumenson

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Medroxyprogesterone acetate (depo-provera) vs. hydroxyprogesterone caproate (delalutin) in women with metastatic endometrial adenocarcinoma'. Together they form a unique fingerprint.